Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes
NCT06334133Phase 3Active, not recruiting
- Sponsor
- vTv Therapeutics
- Start
- Jun 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cadisegliatin in type 1 diabetes mellitus (T1D), sponsored by vTv Therapeutics. Started Jun 2024; status: active, not recruiting.
02
Drugs
cadisegliatin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06334133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334133.